{
  "currency": "USD",
  "company_name": "Hims & Hers Health, Inc.",
  "metrics": {
    "Revenue": {
      "2024": 1477,
      "2023": 872,
      "2022": 527,
      "2021": 272,
      "2020": 149
    },
    "Revenue Growth": {
      "2024": "69.3%",
      "2023": "65.5%",
      "2022": "93.8%",
      "2021": "82.8%",
      "2020": "80.2%"
    },
    "Gross Profit": {
      "2024": 1173,
      "2023": 715,
      "2022": 409,
      "2021": 204,
      "2020": 109
    },
    "Gross Margin": {
      "2024": 0.79,
      "2023": 0.82,
      "2022": 0.78,
      "2021": 0.75,
      "2020": 0.74
    },
    "EBITDA": {
      "2024": 79,
      "2023": -20,
      "2022": -61,
      "2021": -111,
      "2020": -14
    },
    "EBITDA Margin": {
      "2024": 0.05,
      "2023": -0.02,
      "2022": -0.12,
      "2021": -0.41,
      "2020": -0.09
    },
    "FCF": {
      "2024": 209,
      "2023": 47,
      "2022": -34,
      "2021": -39,
      "2020": -7
    },
    "FCF Conversion": {
      "2024": 1.66,
      "2023": -2.0,
      "2022": 0.51,
      "2021": 0.37,
      "2020": 0.37
    },
    "ROIC": {
      "2024": "22.2%",
      "2023": "-9.0%",
      "2022": "-21.3%",
      "2021": "-32.5%",
      "2020": "-14.7%"
    },
    "EV/EBITDA": {
      "2024": 63.45,
      "2023": -89.1,
      "2022": -20.74,
      "2021": -10.43,
      "2020": -34.7
    },
    "PE Ratio": {
      "2024": 41.43,
      "2023": -79.13,
      "2022": -19.96,
      "2021": -11.36,
      "2020": -28.5
    },
    "PB Ratio": {
      "2024": 10.95,
      "2023": 5.42,
      "2022": 4.21,
      "2021": 3.66,
      "2020": -3.51
    },
    "CFO": {
      "2024": 251,
      "2023": 73,
      "2022": -27,
      "2021": -34,
      "2020": -2
    }
  }
}